TheProfitWatch

BBIO - BridgeBio Pharma, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
56.5 -0.92 (-1.63%) --- --- -1.05 (-1.85%) 0.0 (0.0%) 0.02 (0.04%) -1.05 (-1.85%) -1.05 (-1.85%)

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.95
Diluted EPS:
-0.95
Basic P/E:
-58.5053
Diluted P/E:
-58.5053
RSI(14) 1m:
0.0
VWAP:
55.59
RVol:
0.7158

Events

Period Kind Movement Occurred At

Related News